Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors
Cell therapies first reached patients as treatments for blood cancers. Adaptimmune Therapeutics’ work in this therapeutic modality has culminated in ...
Tuesday, January 7, 2025
Tag: Tumors
New FDA Nod Brings Bristol Myers Squibb Cancer Drug to a Wider Range of Solid Tumors
A Bristol Myers Squibb drug initially approved for treating lung cancer now has an additional FDA approval that expands its ...
Explore Israel's diverse narratives with The Israel Chronicle. Stay informed with unbiased reporting, insightful analysis, and comprehensive coverage of politics, culture, technology, and more. Discover the heartbeat of Israel through our trusted news platform.